Predictions
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€529.00
18.12.23
18.12.23
€558.00
18.12.24
18.12.24
6.62%
06.01.24
06.01.24
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
MicroVision Inc
Start price
Target price
Perf. (%)
€2.44
02.12.23
02.12.23
€2.00
02.12.24
02.12.24
-1.29%
05.12.23
05.12.23
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
MicroVision Inc
Start price
Target price
Perf. (%)
€2.36
29.11.23
29.11.23
€2.00
29.11.24
29.11.24
3.49%
02.12.23
02.12.23
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
MicroVision Inc
Start price
Target price
Perf. (%)
€2.23
23.11.23
23.11.23
€2.00
23.11.24
23.11.24
5.92%
29.11.23
29.11.23
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Amgen Inc.
Start price
Target price
Perf. (%)
€246.80
19.09.23
19.09.23
€250.00
19.09.24
19.09.24
4.13%
27.09.23
27.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€502.50
17.08.23
17.08.23
€510.00
17.08.24
17.08.24
10.75%
13.09.23
13.09.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Johnson & Johnson
Start price
Target price
Perf. (%)
€152.60
24.07.23
24.07.23
€155.00
24.07.24
24.07.24
3.47%
16.08.23
16.08.23
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€90.50
28.06.23
28.06.23
€120.00
31.01.26
31.01.26
64.64%
30.07.23
30.07.23
Could be very worthwhile Investment >20% year
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€60.00
08.09.22
08.09.22
€80.00
31.12.24
31.12.24
35.00%
24.06.23
24.06.23
Could be very worthwhile Investment >20% year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€388.00
05.05.23
05.05.23
€395.00
05.05.24
05.05.24
3.52%
12.05.23
12.05.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Seagen Inc.
Start price
Target price
Perf. (%)
€165.90
15.08.22
15.08.22
€180.00
31.01.24
31.01.24
9.64%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€16.10
07.05.22
07.05.22
€20.00
07.05.23
07.05.23
222.26%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.50
03.01.23
03.01.23
€30.00
31.12.25
31.12.25
76.00%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€16.97
06.02.23
06.02.23
€27.00
31.12.25
31.12.25
87.64%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Immunogen Inc.
Start price
Target price
Perf. (%)
€3.98
09.01.23
09.01.23
€8.00
31.12.25
31.12.25
178.89%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€6.10
19.12.22
19.12.22
€18.00
31.12.24
31.12.24
226.15%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€66.50
30.09.22
30.09.22
€120.00
31.12.24
31.12.24
324.36%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€47.20
07.02.23
07.02.23
€50.00
07.02.25
07.02.25
100.21%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
IVERIC bio Inc.
Start price
Target price
Perf. (%)
€17.23
29.09.22
29.09.22
€26.00
31.12.24
31.12.24
98.47%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€233.45
25.04.22
25.04.22
€250.00
25.04.23
25.04.23
14.61%
26.04.23
26.04.23
Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
Seagen Inc.
Start price
Target price
Perf. (%)
€152.08
07.09.22
07.09.22
€180.00
31.12.24
31.12.24
21.00%
21.03.23
21.03.23
Could be very worthwhile Investment >20% year
Meridian Bioscience Inc.
Start price
Target price
Perf. (%)
€19.00
28.01.22
28.01.22
€20.00
28.01.23
28.01.23
62.63%
29.01.23
29.01.23
Could be worthwhile Investment >10% per year
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€407.05
24.01.22
24.01.22
€418.00
24.01.23
24.01.23
10.66%
25.01.23
25.01.23
Could be worthwhile Investment >10% per year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€32.60
28.12.22
28.12.22
€40.00
28.12.23
28.12.23
50.15%
02.01.23
02.01.23